Sign in

CIK 0001861123 · <br>Emerging growth company

Eikon Therapeutics, Inc.

Sign in to watch
Ticker
EIKN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
842807586
Phone
341-777-0566
Business address
230 HARRIET TUBMAN WAY, MILLBRAE, CA, 94030
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 8-K Event Regulation FD disclosure · Other events
  4. 8-K Event Regulation FD disclosure · Other events
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. 4 Open-market buy 10% owner bought 89,200 shares at $11.56 ($1,031,045)
  8. 8-K Event Regulation FD disclosure
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 8-K Event Executive or director change
  13. 3 Insider Initial Statement of Ownership
  14. 8-K Event Executive or director change
  15. 8-K Event Regulation FD disclosure · Other events
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations · Regulation FD disclosure
  20. SCHEDULE 13G Stake Statement of Beneficial Ownership

Page 1 of 4 · 69 filings